<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00693823</url>
  </required_header>
  <id_info>
    <org_study_id>003-179, Viabahn #1</org_study_id>
    <nct_id>NCT00693823</nct_id>
  </id_info>
  <brief_title>Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Femoral Artery Occlusive Disease</brief_title>
  <official_title>A Prospective Randomized Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Superficial Femoral Artery Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Vascular Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Vascular Associates</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a comparison of two different ways to treat blockage in the artery of the
      thigh. The first is an older way with incisions in the groin and just above the knee. A
      plastic tube is then inserted to make a bypass from the groin to the knee. The second
      treatment offered is through a needle hole in the groin. A thin plastic tube covering a metal
      stent is inserted into the artery and released to bypass the blockage from inside the artery.
      No incisions are needed. Patients are enrolled and then selected for one treatment method or
      another by chance. The patients will be followed for two years to see how the two different
      treatment methods work compared to each other.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary artery/graft patency</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Limb Salvage</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in symptoms of lower extremity Ischemia</measure>
    <time_frame>24 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary artery/graft patency</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Lower Extremity Ischemia</condition>
  <condition>Claudication</condition>
  <condition>Rest Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Femoral-popliteal surgical bypass with prosthetic graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interventional angioplasty and placement of an ePTFE covered stent graft within the femoral-popliteal artery as an endoluminal bypass percutaneously</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femoral-popliteal Bypass</intervention_name>
    <description>Surgical placement of a prosthetic graft in the thigh from the groin to the knee</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angioplasty and stent placement with Viabahn covered stent-graft(W.L. Gore &amp; Associates, Flagstff, Arizona) of superficial femoral artery</intervention_name>
    <description>Placement of an ePTFE covered stent graft within the superficial femoral artery in the thigh through a needle hole percutaneously</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Viabahn endoprosthesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Patients that had atherosclerotic stenotic or occlusive lesions of the
        superficial femoral artery with no significant aorto-iliac disease. The infra-popliteal
        segment had to be patent with at least single vessel run-off to the ankle. Patients had to
        be acceptable surgical candidates in the event they were randomized to the surgical arm.

        Exclusion Criteria:Non-operative candidate,Contraindication to IV contrast use, Planned
        surgery with venous conduit, previously stented segment of the superficial femoral artery,
        poorly compliant patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P, Becker GJ, Settlage RA. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000 Oct;217(1):95-104.</citation>
    <PMID>11012429</PMID>
  </reference>
  <reference>
    <citation>Hartung O, Otero A, Dubuc M, Boufi M, Barthelemy P, Aissi K, Alimi YS. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg. 2005 Sep;30(3):300-6.</citation>
    <PMID>15936230</PMID>
  </reference>
  <reference>
    <citation>Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther. 2006 Jun;13(3):281-90.</citation>
    <PMID>16784314</PMID>
  </reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2008</study_first_submitted>
  <study_first_submitted_qc>June 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2008</study_first_posted>
  <last_update_submitted>June 6, 2008</last_update_submitted>
  <last_update_submitted_qc>June 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dennis R. Gable, M.D.</name_title>
    <organization>Texas Vascular Associates/Baylor University Medical Center</organization>
  </responsible_party>
  <keyword>atherosclerosis</keyword>
  <keyword>stent</keyword>
  <keyword>angioplasty</keyword>
  <keyword>covered stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

